AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Unique Class of Cyanooxime Carbonyl Reductase Inhibitors (CyanOx-CRIs) to Lower Cardiotoxicity of Anthracycline Agents
Technology Benefits
Increases the efficacy of anthracycline therapy in cancer treatments. Reduces the amount of carbonyl reductase created, reducing the negative effects on the heart. Uses the FDA approved drug anthracycline to reduce the effect of carbonyl reductase. Results in healthier cancer patients after treatment due to the reduced amount of metabolites causing cardiotoxicity.
Detailed Technology Description
None
Industry
Biomedical
Sub Group
Medical Composition
Country/Region
USA
For more information, please click Here
